Optimal vitamin D supplementation doses that minimize the risk for both low and high serum 25-hydroxyvitamin D concentrations in the general population

Nutrients

Volumn 7, Issue 12, 2015, Pages 10189-10208

  Veugelers, Paul J ^a   Pham, Truong Minh ^a   Ekwaru, John Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Disease prevention; Nutrition; Optimal vitamin D intake; Optimal vitamin D status; Public health; Recommended daily allowance; Vitamin D; Vitamin D deficiency; Vitamin D supplementation

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ARTICLE; CLINICAL ASSESSMENT; DIETARY INTAKE; DIETARY REFERENCE INTAKE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; QUESTIONNAIRE; VITAMIN SUPPLEMENTATION; ADULT; BLOOD; DIETARY SUPPLEMENT; DOSE RESPONSE; FEMALE; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RISK FACTOR; VITAMIN D DEFICIENCY;

ADULT; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; RECOMMENDED DIETARY ALLOWANCES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84949604596     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7125527     Document Type: Article

References (103)

1. Institute of Medicine; Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D; National Academies Press: Washington, DC, USA, 2011.
2. Maxmen, A. Nutrition advice: The vitamin D-lemma. Nature 2011, 475, 23-25.
3. Holick, M. F.; Binkley, N. C.; Bischoff-Ferrari, H. A.; Gordon, C. M.; Hanley, D. A.; Heaney, R. P.; Murad, M. H.; Weaver, C. M.; Endocrine, S. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911-1930.
4. Ekwaru, J. P.; Zwicker, J. D.; Holick, M. F.; Giovannucci, E.; Veugelers, P. J. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS ONE 2014, 9, e111265.
5. Zittermann, A.; Ernst, J. B.; Gummert, J. F.; Borgermann, J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: A systematic review. Eur. J. Nutr. 2014, 53, 367-374.
6. Van Groningen, L.; Opdenoordt, S.; van Sorge, A.; Telting, D.; Giesen, A.; de Boer, H. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 2010, 162, 805-811.
7. Heaney, R. P.; Davies, K. M.; Chen, T. C.; Holick, M. F.; Barger-Lux, M. J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003, 77, 204-210.
8. Janz, T.; Pearson, C. Vitamin D Blood Levels of Canadians. In Health at a Glance, Statistics Canada (Catalogue No. 82-624-X); Statistics Canada: Ottawa, ON, Canada, 2013.
9. Greene-Finestone, L.; Berger, C.; de Groh, M.; Hanley, D.; Hidiroglou, N.; Sarafin, K.; Poliquin, S.; Krieger, J.; Richards, J.; Goltzman, D. 25-Hydroxyvitamin D in Canadian adults: Biological, environmental, and behavioral correlates. Osteoporos. Int. 2011, 22, 1389-1399.
10. Veugelers, P. J.; Ekwaru, J. P. A Statistical Error in the Estimation of the Recommended Dietary Allowance for Vitamin D. Nutrients 2014, 6, 4472-4475, doi: 10. 3390/nu6104472.
11. Heaney, R.; Garland, C.; Baggerly, C.; French, C.; Gorham, E. Letter to Veugelers, P. J. and Ekwaru, J. P., A Statistical Error in the Estimation of the Recommended Dietary Allowance for Vitamin D. Nutrients 2015, 7, 1688-1690.
12. Garland, C. F.; French, C. B.; Baggerly, L. L.; Heaney, R. P. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011, 31, 607-611.
13. Pham, T. M.; Ekwaru, J. P.; Setayeshgar, S.; Veugelers, P. J. The Effect of Changing Serum 25-Hydroxyvitamin D Concentrations on Metabolic Syndrome: A Longitudinal Analysis of Participants of a Preventive Health Program. Nutrients 2015, 7, 7271-7284.
14. Ekwaru, J. P.; Ohinmaa, A.; Veugelers, P. J. The effectiveness of a preventive health program and vitamin D status in improving health-related quality of life of older Canadians. Qual. Life Res. 2015, doi: 10. 1007/s11136-015-1103-7.
15. Koenker, R.; Bassett, G., Jr. Regression quantiles. Econom. J. Econom. Soc. 1978, 46, 33-50.
16. Luxwolda, M. F.; Kuipers, R. S.; Kema, I. P.; Dijck-Brouwer, D. A.; Muskiet, F. A. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br. J. Nutr. 2012, 108, 1557-1561.
17. Ala-Houhala, M.; Koskinen, T.; Koskinen, M.; Visakorpi, J. K. Double blind study on the need for vitamin D supplementation in prepubertal children. Acta Paediatr. Scand. 1988, 77, 89-93.
18. Aloia, J.; Bojadzievski, T.; Yusupov, E.; Shahzad, G.; Pollack, S.; Mikhail, M.; Yeh, J. The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J. Clin. Endocrinol. Metab. 2010, 95, 3216-3224.
19. Aloia, J. F.; Talwar, S. A.; Pollack, S.; Yeh, J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch. Intern. Med. 2005, 165, 1618-1623.
20. Biancuzzo, R. M.; Young, A.; Bibuld, D.; Cai, M. H.; Winter, M. R.; Klein, E. K.; Ameri, A.; Reitz, R.; Salameh, W.; Chen, T. C.; et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am. J. Clin. Nutr. 2010, 91, 1621-1626.
21. Bolton-Smith, C.; McMurdo, M. E.; Paterson, C. R.; Mole, P. A.; Harvey, J. M.; Fenton, S. T.; Prynne, C. J.; Mishra, G. D.; Shearer, M. J. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J. Bone Miner. Res. 2007, 22, 509-519.
22. Cashman, K. D.; Seamans, K. M.; Lucey, A. J.; Stocklin, E.; Weber, P.; Kiely, M.; Hill, T. R. Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am. J. Clin. Nutr. 2012, 95, 1350-1356.
23. Dawson-Hughes, B.; Dallal, G. E.; Krall, E. A.; Harris, S.; Sokoll, L. J.; Falconer, G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann. Intern. Med. 1991, 115, 505-512.
24. Dawson-Hughes, B.; Harris, S. S.; Krall, E. A.; Dallal, G. E.; Falconer, G.; Green, C. L. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am. J. Clin. Nutr. 1995, 61, 1140-1145.
25. Diamond, T.; Wong, Y. K.; Golombick, T. Effect of oral cholecalciferol 2000 versus 5000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos. Int. 2013, 24, 1101-1105.
26. Gallagher, J. C.; Jindal, P. S.; Smith, L. M. Vitamin D supplementation in young White and African American women. J. Bone Miner. Res. 2014, 29, 173-181.
27. Harris, S. S.; Pittas, A. G.; Palermo, N. J. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes. Metab. 2012, 14, 789-794.
28. Holick, M. F.; Biancuzzo, R. M.; Chen, T. C.; Klein, E. K.; Young, A.; Bibuld, D.; Reitz, R.; Salameh, W.; Ameri, A.; Tannenbaum, A. D. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 2008, 93, 677-681.
29. Jensen, C.; Holloway, L.; Block, G.; Spiller, G.; Gildengorin, G.; Gunderson, E.; Butterfield, G.; Marcus, R. Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am. J. Clin. Nutr. 2002, 75, 1114-1120.
30. Karkkainen, M. K.; Tuppurainen, M.; Salovaara, K.; Sandini, L.; Rikkonen, T.; Sirola, J.; Honkanen, R.; Arokoski, J.; Alhava, E.; Kroger, H. Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65-71 years? A 3-year randomized population-based trial (OSTPRE-FPS). Maturitas 2010, 65, 359-365.
31. Kilpinen-Loisa, P.; Arvio, M.; Ilvesmaki, V.; Makitie, O. Vitamin D status and optimal supplementation in institutionalized adults with intellectual disability. J. Intellect. Disabil. Res. JIDR 2009, 53, 1014-1023.
32. Kyriakidou-Himonas, M.; Aloia, J. F.; Yeh, J. K. Vitamin D supplementation in postmenopausal black women. J. Clin. Endocrinol. Metab. 1999, 84, 3988-3990.
33. Lagunova, Z.; Porojnicu, A. C.; Aksnes, L.; Holick, M. F.; Iani, V.; Bruland, O. S.; Moan, J. Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: A randomized, crossover clinical trial. Br. J. Dermatol. 2013, 169, 434-440.
34. Lappe, J. M.; Travers-Gustafson, D.; Davies, K. M.; Recker, R. R.; Heaney, R. P. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am. J. Clin. Nutr. 2007, 85, 1586-1591.
35. Li-Ng, M.; Aloia, J. F.; Pollack, S.; Cunha, B. A.; Mikhail, M.; Yeh, J.; Berbari, N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect. 2009, 137, 1396-1404.
36. Logan, V. F.; Gray, A. R.; Peddie, M. C.; Harper, M. J.; Houghton, L. A. Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br. J. Nutr. 2013, 109, 1082-1088.
37. Molgaard, C.; Larnkjaer, A.; Cashman, K. D.; Lamberg-Allardt, C.; Jakobsen, J.; Michaelsen, K. F. Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization? Bone 2010, 46, 432-439.
38. Nelson, M. L.; Blum, J. M.; Hollis, B. W.; Rosen, C.; Sullivan, S. S. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J. Nutr. 2009, 139, 540-546.
39. Oosterwerff, M. M.; Eekhoff, E. M.; van Schoor, N. M.; Boeke, A. J.; Nanayakkara, P.; Meijnen, R.; Knol, D. L.; Kramer, M. H.; Lips, P. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: A randomized placebo-controlled trial. Am. J. Clin. Nutr. 2014, 100, 152-160.
40. Orwoll, E. S.; McClung, M. R.; Oviatt, S. K.; Recker, R. R.; Weigel, R. M. Histomorphometric effects of calcium or calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis. J. Bone Miner. Res. 1989, 4, 81-88.
41. Orwoll, E. S.; Weigel, R. M.; Oviatt, S. K.; McClung, M. R.; Deftos, L. J. Calcium and cholecalciferol: Effects of small supplements in normal men. Am. J. Clin. Nutr. 1988, 48, 127-130.
42. Pignotti, G. A.; Genaro, P. S.; Pinheiro, M. M.; Szejnfeld, V. L.; Martini, L. A. Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country? Eur. J. Nutr. 2010, 49, 277-283.
43. Putman, M. S.; Pitts, S. A.; Milliren, C. E.; Feldman, H. A.; Reinold, K.; Gordon, C. M. A randomized clinical trial of vitamin D supplementation in healthy adolescents. J. Adolesc. Health Off. Publ. Soc. Adolesc. Med. 2013, 52, 592-598.
44. Rajakumar, K.; Fernstrom, J. D.; Holick, M. F.; Janosky, J. E.; Greenspan, S. L. Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children. Obesity (Silver Spring) 2008, 16, 90-95.
45. Schaafsma, A.; Muskiet, F. A.; Storm, H.; Hofstede, G. J.; Pakan, I.; van der Veer, E. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: Effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur. J. Clin. Nutr. 2000, 54, 626-631.
46. Schnatz, P. F.; Jiang, X.; Vila-Wright, S.; Aragaki, A. K.; Nudy, M.; O'Sullivan, D. M.; Jackson, R.; LeBlanc, E.; Robinson, J. G.; Shikany, J. M.; et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause 2014, 21, 823-833.
47. Schou, A. J.; Heuck, C.; Wolthers, O. D. A randomized, controlled lower leg growth study of vitamin D supplementation to healthy children during the winter season. Ann. Hum. Biol. 2003, 30, 214-219.
48. Smith, S. M.; Gardner, K. K.; Locke, J.; Zwart, S. R. Vitamin D supplementation during Antarctic winter. Am. J. Clin. Nutr. 2009, 89, 1092-1098.
49. Van Der Klis, F. R.; Jonxis, J. H.; van Doormaal, J. J.; Sikkens, P.; Saleh, A. E.; Muskiet, F. A. Changes in vitamin-D metabolites and parathyroid hormone in plasma following cholecalciferol administration to preand postmenopausal women in the Netherlands in early spring and to postmenopausal women in Curacao. Br. J. Nutr. 1996, 75, 637-646.
50. Vieth, R.; Chan, P. C.; MacFarlane, G. D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr. 2001, 73, 288-294.
51. Wamberg, L.; Pedersen, S. B.; Richelsen, B.; Rejnmark, L. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: Results from a randomized controlled study. Calcif. Tissue Int. 2013, 93, 69-77.
52. Zwart, S. R.; Mehta, S. K.; Ploutz-Snyder, R.; Bourbeau, Y.; Locke, J. P.; Pierson, D. L.; Smith, S. M. Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr Virus Reactivation. J. Nutr. 2011, 141, 692-697.
53. Statistics Canada. Vitamin D Levels of Canadians. 2012 to 2013. Available online: http://www. statcan. gc. ca/pub/82-625-x/2014001/article/14125-eng. htm (accessed on 11 August 2015).
54. Holick, M. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
55. Thacher, T. D.; Clarke, B. L. Vitamin D insufficiency. Mayo Clin. Proc. 2011, 86, 50-60.
56. Hagenau, T.; Vest, R.; Gissel, T. N.; Poulsen, C. S.; Erlandsen, M.; Mosekilde, L.; Vestergaard, P. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: An ecologic meta-regression analysis. Osteoporos. Int. 2009, 20, 133-140.
57. Hilger, J.; Friedel, A.; Herr, R.; Rausch, T.; Roos, F.; Wahl, D. A.; Pierroz, D. D.; Weber, P.; Hoffmann, K. A systematic review of vitamin D status in populations worldwide. Br. J. Nutr. 2014, 111, 23-45.
58. Wahl, D. A.; Cooper, C.; Ebeling, P. R.; Eggersdorfer, M.; Hilger, J.; Hoffmann, K.; Josse, R.; Kanis, J. A.; Mithal, A.; Pierroz, D. D.; et al. A global representation of vitamin D status in healthy populations. Arch. Osteoporos. 2012, 7, 155-172.
59. Vatanparast, H.; Calvo, M. S.; Green, T. J.; Whiting, S. J. Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. J. Steroid Biochem. Mol. Biol. 2010, 121, 301-303.
60. Munasinghe, L. L.; Willows, N.; Yuan, Y.; Veugelers, P. J. Dietary reference intakes for vitamin D based on the revised 2010 dietary guidelines are not being met by children in Alberta, Canada. Nutr. Res. 2015, 35, 956-964.
61. Crowe, F. L.; Steur, M.; Allen, N. E.; Appleby, P. N.; Travis, R. C.; Key, T. J. Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: Results from the EPIC-Oxford study. Public Health Nutr. 2011, 14, 340-346.
62. Dawson-Hughes, B.; Harris, S. S.; Lichtenstein, A. H.; Dolnikowski, G.; Palermo, N. J.; Rasmussen, H. Dietary fat increases vitamin D-3 absorption. J. Acad. Nutr. Diet. 2015, 115, 225-230.
63. Mulligan, G. B.; Licata, A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J. Bone Miner. Res. 2010, 25, 928-930.
64. Raimundo, F. V.; Faulhaber, G. A.; Menegatti, P. K.; Marques Lda, S.; Furlanetto, T. W. Effect of High-versus Low-Fat Meal on Serum 25-Hydroxyvitamin D Levels after a Single Oral Dose of Vitamin D: A Single-Blind, Parallel, Randomized Trial. Int. J. Endocrinol. 2011, 2011, 809069.
65. Ahn, J.; Yu, K.; Stolzenberg-Solomon, R.; Simon, K. C.; McCullough, M. L.; Gallicchio, L.; Jacobs, E. J.; Ascherio, A.; Helzlsouer, K.; Jacobs, K. B.; et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 2010, 19, 2739-2745.
66. Barry, E. L.; Rees, J. R.; Peacock, J. L.; Mott, L. A.; Amos, C. I.; Bostick, R. M.; Figueiredo, J. C.; Ahnen, D. J.; Bresalier, R. S.; Burke, C. A.; et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J. Clin. Endocrinol. Metab. 2014, 99, E2133-2137.
67. Buijsse, B.; Boeing, H.; Hirche, F.; Weikert, C.; Schulze, M. B.; Gottschald, M.; Kuhn, T.; Katzke, V. A.; Teucher, B.; Dierkes, J.; et al. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: A prospective case-cohort study. Eur. J. Epidemiol. 2013, 28, 743-752.
68. Didriksen, A.; Grimnes, G.; Hutchinson, M. S.; Kjaergaard, M.; Svartberg, J.; Joakimsen, R. M.; Jorde, R. The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 2013, 169, 559-567.
69. Engelman, C. D.; Meyers, K. J.; Iyengar, S. K.; Liu, Z.; Karki, C. K.; Igo, R. P., Jr.; Truitt, B.; Robinson, J.; Sarto, G. E.; Wallace, R.; et al. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J. Nutr. 2013, 143, 17-26.
70. Hansen, J. G.; Tang, W.; Hootman, K. C.; Brannon, P. M.; Houston, D. K.; Kritchevsky, S. B.; Harris, T. B.; Garcia, M.; Lohman, K.; Liu, Y.; et al. Genetic and environmental factors are associated with serum 25-hydroxyvitamin D concentrations in older African Americans. J. Nutr. 2015, 145, 799-805.
71. Levin, G. P.; Robinson-Cohen, C.; de Boer, I. H.; Houston, D. K.; Lohman, K.; Liu, Y.; Kritchevsky, S. B.; Cauley, J. A.; Tanaka, T.; Ferrucci, L.; et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA 2012, 308, 1898-1905.
72. Sollid, S. T.; Hutchinson, M. Y.; Fuskevag, O. M.; Joakimsen, R. M.; Jorde, R. Large Individual Differences in Serum 25-Hydroxyvitamin D Response to Vitamin D Supplementation: Effects of Genetic Factors, Body Mass Index, and Baseline Concentration. Results from a Randomized Controlled Trial. Horm. Metab. Res. 2015, doi: 10. 1055/s-0034-1398617.
73. Wang, T. J.; Zhang, F.; Richards, J. B.; Kestenbaum, B.; van Meurs, J. B.; Berry, D.; Kiel, D. P.; Streeten, E. A.; Ohlsson, C.; Koller, D. L.; et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010, 376, 180-188.
74. Institute of Medicine. How the RDA for Vitamin D Was Determined. Available Online: http://iom. nationalacademies. org/Global/News%20Announcements/How-the-RDA-for-Vitamin-D-Was-Determined (accessed on 8 August 2014).
75. American Geriatrics Society Workgroup on Vitamin, D. S. f. O. A. Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences. J. Am. Geriatr. Soc. 2014, 62, 147-152.
76. Heaney, R. P. The Vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol. 2005, 97, 13-19.
77. Holick, M. F.; Binkley, N. C.; Bischoff-Ferrari, H. A.; Gordon, C. M.; Hanley, D. A.; Heaney, R. P.; Murad, M. H.; Weaver, C. M. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 2012, 97, 1153-1158.
78. Trivedi, D. P.; Doll, R.; Khaw, K. T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. BMJ 2003, 326, 469-469.
79. Bischoff-Ferrari, H. A.; Willett, W. C.; Wong, J. B.; Giovannucci, E.; Dietrich, T.; Dawson-Hughes, B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 2005, 293, 2257-2264.
80. Von Hurst, P. R.; Stonehouse, W.; Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-A randomised, placebo-controlled trial. Br. J. Nutr. 2010, 103, 549-555.
81. Wang, L.; Song, Y.; Manson, J. E.; Pilz, S.; Marz, W.; Michaelsson, K.; Lundqvist, A.; Jassal, S. K.; Barrett-Connor, E.; Zhang, C.; et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 2012, 5, 819-829.
82. Giovannucci, E.; Liu, Y.; Hollis, B. W.; Rimm, E. B. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch. Intern. Med. 2008, 168, 1174-1180.
83. Garland, C. F.; Garland, F. C.; Gorham, E. D.; Lipkin, M.; Newmark, H.; Mohr, S. B.; Holick, M. F. The role of vitamin D in cancer prevention. Am. J. Public Health 2006, 96, 252-261.
84. Garland, C. F.; Gorham, E. D.; Mohr, S. B.; Grant, W. B.; Giovannucci, E. L.; Lipkin, M.; Newmark, H.; Holick, M. F.; Garland, F. C. Vitamin D and prevention of breast cancer: Pooled analysis. J. Steroid Biochem. Mol. Biol. 2007, 103, 708-711.
85. Bolland, M. J.; Grey, A.; Gamble, G. D.; Reid, I. R. Calcium and vitamin D supplements and health outcomes: A reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr. 2011, 94, 1144-1149.
86. Lowe, L. C.; Guy, M.; Mansi, J. L.; Peckitt, C.; Bliss, J.; Wilson, R. G.; Colston, K. W. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur. J. Cancer 2005, 41, 1164-1169.
87. Garland, C. F.; Comstock, G. W.; Garland, F. C.; Helsing, K. J.; Shaw, E. K.; Gorham, E. D. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989, 2, 1176-1178.
88. Grant, W. B. Solar ultraviolet irradiance and cancer incidence and mortality. Adv. Exp. Med. Biol. 2014, 810, 52-68.
89. Munger, K. L.; Levin, L. I.; Hollis, B. W.; Howard, N. S.; Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296, 2832-2838.
90. Ginde, A. A.; Mansbach, J. M.; Camargo, C. A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169, 384-390.
91. Laaksi, I.; Ruohola, J. P.; Tuohimaa, P.; Auvinen, A.; Haataja, R.; Pihlajamki, H.; Ylikomi, T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr. 2007, 86, 714-717.
92. Urashima, M.; Segawa, T.; Okazaki, M.; Kurihara, M.; Wada, Y.; Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010, 91, 1255-1260.
93. Manson, J. E.; Bassuk, S. S. Vitamin D research and clinical practice: At a crossroads. JAMA 2015, 313, 1311-1312.
94. Dror, Y.; Giveon, S. M.; Hoshen, M.; Feldhamer, I.; Balicer, R. D.; Feldman, B. S. Vitamin D levels for preventing acute coronary syndrome and mortality: Evidence of a nonlinear association. J. Clin. Endocrinol. Metab. 2013, 98, 2160-2167.
95. Durup, D.; Jorgensen, H. L.; Christensen, J.; Tjonneland, A.; Olsen, A.; Halkjaer, J.; Lind, B.; Heegaard, A. M.; Schwarz, P. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study. J. Clin. Endocrinol. Metab. 2015, 100, 2339-2346.
96. Xu, Y.; Shao, X.; Yao, Y.; Xu, L.; Chang, L.; Jiang, Z.; Lin, Z. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: New findings from an updated meta-analysis. J. Cancer Res. Clin. Oncol. 2014, 140, 1465-1477.
97. Zittermann, A.; Kuhn, J.; Dreier, J.; Knabbe, C.; Gummert, J. F.; Borgermann, J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur. Heart J. 2013, 34, 1358-1364.
98. Zittermann, A.; Kuhn, J.; Ernst, J. B.; Becker, T.; Dreier, J.; Knabbe, C.; Gummert, J. F.; Borgermann, J. 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D and postoperative outcome in cardiac surgery. J. Clin. Endocrinol. Metab. 2015, 100, 72-80.
99. Dudenkov, D. V.; Yawn, B. P.; Oberhelman, S. S.; Fischer, P. R.; Singh, R. J.; Cha, S. S.; Maxson, J. A.; Quigg, S. M.; Thacher, T. D. Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study. Mayo Clin. Proc. 2015, 90, 577-586.
100. Bischoff-Ferrari, H. A.; Shao, A.; Dawson-Hughes, B.; Hathcock, J.; Giovannucci, E.; Willett, W. C. Benefit-risk assessment of vitamin D supplementation. Osteoporos. Int. 2010, 21, 1121-1132.
101. Hathcock, J. N.; Shao, A.; Vieth, R.; Heaney, R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85, 6-18.
102. Holick, M. F. Vitamin D Is Not as Toxic as Was Once Thought: A Historical and an Up-to-Date Perspective. Mayo Clin. Proc. 2015, 90, 561-564.
103. Spedding, S.; Vanlint, S.; Morris, H.; Scragg, R. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients 2013, 5, 5127-5139.